XLO
Xilio Therapeutics, Inc. Common Stock
stockNASDAQ
xilio is a waltham, massachusetts-based biopharmaceutical company focused on defeating cancer. the company's proprietary technology enables the explosion of therapeutic activity specifically within the tumor while reducing toxicity throughout the body – a nod to the company name, xilio, derived from the latin term, ex nihilo, meaning creation or big-bang. xilio is applying its technology to build a broad pipeline of engineered antibodies, cytokines and chemokines as potential new options for people living with cancer. to learn more, please visit www.xiliotx.com.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 9.05 | 2026-09-28 | +0.22% | 0.989 |
| 1M | 9.00 | 2026-09-04 | +0.78% | 0.054 |
| 3M | 9.44 | 2026-07-06 | -3.92% | 0.218 |
| 6M | 8.46 | 2026-04-06 | +7.21% | 0.777 |
| 1Y | 11.45 | 2025-10-03 | -20.80% | 0.892 |
| 2Y | 10.92 | 2024-10-04 | -16.94% | — |
| 5Y | 224.00 | 2021-10-22 | -95.95% | 0.883 |
Xilio Therapeutics, Inc. Common Stock (NASDAQ:XLO) stock price today is $9.07, and today's volume is 7,401. XLO is up 1.796% today. The 30 day average volume is 9,515. XLO market cap is $59.68M with 6.58M shares outstanding.